Submitted by Anonymous (not verified) on 20 August 2026 - 13:07
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 20, Status: Authorised